CN104244962A - 用于治疗代谢紊乱的组合物 - Google Patents

用于治疗代谢紊乱的组合物 Download PDF

Info

Publication number
CN104244962A
CN104244962A CN201380021515.3A CN201380021515A CN104244962A CN 104244962 A CN104244962 A CN 104244962A CN 201380021515 A CN201380021515 A CN 201380021515A CN 104244962 A CN104244962 A CN 104244962A
Authority
CN
China
Prior art keywords
extract
composition
terminalia
ellipsoides
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380021515.3A
Other languages
English (en)
Chinese (zh)
Inventor
阿尔温德·萨克拉尼
奈尔什·马尔普瑞
帕瑞克希特·盖克瓦德
萨蒂什·纳姆杜·萨万特
图卡拉姆·凯森劳·马尼
萨姆什·夏尔马
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Life Sciences Ltd
Original Assignee
Piramal Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Life Sciences Ltd filed Critical Piramal Life Sciences Ltd
Publication of CN104244962A publication Critical patent/CN104244962A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201380021515.3A 2012-04-23 2013-04-22 用于治疗代谢紊乱的组合物 Pending CN104244962A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23
US61/636,792 2012-04-23
PCT/IB2013/053155 WO2013160811A1 (en) 2012-04-23 2013-04-22 Composition for treating metabolic disorders

Publications (1)

Publication Number Publication Date
CN104244962A true CN104244962A (zh) 2014-12-24

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380021515.3A Pending CN104244962A (zh) 2012-04-23 2013-04-22 用于治疗代谢紊乱的组合物

Country Status (16)

Country Link
US (1) US20150290265A1 (https=)
EP (1) EP2841080A4 (https=)
JP (1) JP2015514797A (https=)
KR (1) KR20150003862A (https=)
CN (1) CN104244962A (https=)
AU (1) AU2013254329A1 (https=)
BR (1) BR112014026326A2 (https=)
CA (1) CA2870907A1 (https=)
IL (1) IL235317A0 (https=)
IN (1) IN2014MN02269A (https=)
MX (1) MX2014012742A (https=)
NZ (1) NZ701133A (https=)
RU (1) RU2014145931A (https=)
SA (1) SA113340494B1 (https=)
TW (1) TW201343174A (https=)
WO (1) WO2013160811A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233188A4 (en) * 2014-12-19 2018-11-07 Halo Life Science, LLC Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
JP2019533022A (ja) 2016-10-24 2019-11-14 ユマニティ セラピューティクス，インコーポレーテッド 化合物及びその使用
EP3566055B1 (en) 2017-01-06 2025-03-12 Janssen Pharmaceutica NV Scd inhibitor for the treatment of neurological disorders
CA3083000A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. Compounds and uses thereof
AU2019207737B2 (en) 2018-01-10 2023-07-13 Brightseed, Inc. Method for modulating metabolism
WO2019183587A1 (en) 2018-03-23 2019-09-26 Yumanity Therapeutics, Inc. Compounds and uses thereof
WO2020154571A1 (en) 2019-01-24 2020-07-30 Yumanity Therapeutics, Inc. Compounds and uses thereof
JP2023501483A (ja) 2019-11-11 2023-01-18 ブライトシード・インコーポレイテッド 抽出物、消費可能な製品及び抽出物における生物活性代謝産物を濃縮するための方法
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
KR102408566B1 (ko) * 2020-04-09 2022-06-16 대한민국 터미날리아 비아라타 추출물을 이용한 피부 주름 개선용 조성물
JP2023144436A (ja) * 2022-03-28 2023-10-11 住友化学株式会社 エラグ酸含有組成物の製造方法及びエラグ酸含有組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101443024A (zh) * 2005-02-23 2009-05-27 阿维斯塔金格兰技术有限公司 植物提取物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (ja) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk 糖尿病疾患予防・治療剤
JP2006188486A (ja) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk 体脂肪蓄積抑制または低減剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101443024A (zh) * 2005-02-23 2009-05-27 阿维斯塔金格兰技术有限公司 植物提取物及其制备方法和应用
US20100129478A1 (en) * 2005-02-23 2010-05-27 Villoo Morawala Patell Plant Extracts and Methods and Uses Therefore

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MANJUAN LIU等: "Phytochemical and antifungal studies on Terminalia mollis and Terminalia brachystemma", 《FITOTERAPIA》 *
S.A.A. EL-TOUMY等: "Ellagi- and gallotannins from Punica granatum heartwood", 《PHARMAZIE》 *
TAKASHI YOSHIDA等: "Structural Features and Biological Properties of Ellagitannins in Some Plant Families of the Order Myrtales", 《INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES》 *
朱敬等: "天然药物的抗糖尿病及抗微血管并发症的作用", 《国外医药.植物药分册》 *

Also Published As

Publication number Publication date
JP2015514797A (ja) 2015-05-21
SA113340494B1 (ar) 2015-12-24
TW201343174A (zh) 2013-11-01
EP2841080A1 (en) 2015-03-04
US20150290265A1 (en) 2015-10-15
RU2014145931A (ru) 2016-06-20
MX2014012742A (es) 2015-04-08
AU2013254329A1 (en) 2014-11-13
NZ701133A (en) 2016-08-26
IN2014MN02269A (https=) 2015-07-24
KR20150003862A (ko) 2015-01-09
CA2870907A1 (en) 2013-10-31
BR112014026326A2 (pt) 2017-06-27
EP2841080A4 (en) 2015-11-25
WO2013160811A1 (en) 2013-10-31
IL235317A0 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
CN104244962A (zh) 用于治疗代谢紊乱的组合物
Süntar et al. Comparative evaluation of traditional prescriptions from Cichorium intybus L. for wound healing: Stepwise isolation of an active component by in vivo bioassay and its mode of activity
Zeashan et al. Hepatoprotective activity of Amaranthus spinosus in experimental animals
RU2349337C2 (ru) Фармацевтическая композиция, содержащая стероидные сапонины, способ ее получения и ее применение
Liu et al. An in vivo and in vitro assessment of the anti-inflammatory, antinociceptive, and immunomodulatory activities of Clematis terniflora DC. extract, participation of aurantiamide acetate
JP2004501202A (ja) ソホラフラヴェスセンス抽出物またはソホラサブプロストラータ抽出物の治療への使用
Razak et al. Ameliorative effects of aquilaria malaccensis leaves aqueous extract on reproductive toxicity induced by cyclophosphamide in male rats
Ilango et al. Antidiabetic, antioxidant and antibacterial activities of leaf extracts of Adhatoda zeylanica. Medic (Acanthaceae)
CN101918080B (zh) 欧洲白蜡树种子提取物及其治疗应用
Lin et al. Antidiabetic and antihyperlipidemic effects of the flower extract of Eriobotrya japonica in streptozotocin-induced diabetic mice and the potential bioactive constituents in vitro
Tatipamula et al. Fibrinolytic, anti-inflammatory and cytotoxic potentialities of extracts and chemical constituents of manglicolous lichen, Graphis ajarekarii Patw. & CR Kulk
CN105030802B (zh) 一种木脂素类化合物的应用
US20150050373A1 (en) Herbal composition for the treatment of metabolic disorders
AU2006296197A1 (en) Herbal composition for inflammatory disorders
JP2000503686A (ja) 黄栢皮とオミナエシ植物の混合抽出物を含有するｃ型肝炎治療用製薬組成物
US20060246161A1 (en) Method of making medicament for treating anemia
CN114736182A (zh) 一种抗心肌缺血再灌注损伤的化合物和傣药组合物及其应用
Sirisa-Ard et al. Chemical Composition, Antibacterial and Antioxidant activities of Extracts from Dry Leaves and Ash-Dry Leaves of Luffa cylindrica (L.) Roem Cultivated in Vietnam
JP2008543966A (ja) トウダイグサ科植物乳液からの極性溶媒抽出物の活性画分
KR101084733B1 (ko) 물오리나무 줄기 추출물 또는 이로부터 분리된 화합물을 함유하는 간독성 질환 예방 및 치료용 조성물
Mangathayaru et al. Estrogenic effect of Erythrina variegata L. in prepubertal female rats
Pal et al. A Review on Phyto-Pharmacological Aspects of Apamarg (Achyranthes aspera Linn.)
Boutellaa et al. Nephroprotective Effect of Hertiacheirifolia Polar Fraction with Selenium against Carbon Tetrachloride in Rats
KR101339728B1 (ko) 말라바리콘 시를 함유하는 혈관 질환의 치료 또는 예방용 조성물
Kushwaha et al. Hepatoprotective activity of ethanolic extract of Euphorbia royleana linn in carbon tetrachloride treated guinea pig

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141224